Evidence map›Paper›PMID 40740164›Full record

ArticleACS applied nano materials2024

The Predictive Synthesis of Monodisperse and Biocompatible Gold Nanoparticles.

Alex N Frickenstein, Nathan Means, Yuxin He, Luke Whitehead, Tekena Harcourt, Zain Malik, Vinit Sheth, Logan Longacre, Haley Taffe, Lin Wang and 5 more

Abstract read
In one paragraph

Article in ACS applied nano materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Axially Swept Light-Sheet Microscopy using scattering and fluorescence contrast mechanisms.Proceedings of SPIE--the International Society for Optical Engineering · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alex N FrickensteinStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Nathan MeansStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Yuxin HeStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Luke WhiteheadStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Tekena HarcourtStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Zain MalikStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Vinit ShethStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Logan LongacreStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Haley TaffeStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Lin WangStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.ORCID 0000-0003-4636-8225
Isabella McSpaddenStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Connor BaroodyStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.
Wen YangStephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States.ORCID 0000-0001-9206-0868
Yan D ZhaoDepartment of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73012, United States; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States.
Stefan WilhelmStephenson School of Biomedical Engineering and Institute for Biomedical Engineering, Science, and Technology (IBEST), University of Oklahoma, Norman, Oklahoma 73019, United States; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States.ORCID 0000-0003-2167-6221

Funding

Use of 3D Quantitative Optical Methods to Optimize Mebendazole Treatment of Ovarian CancerP20GM135009 · NIGMS · UNIVERSITY OF OKLAHOMA · PI Javier Antonio Jo · 2022 to 2026
$13.6M
A novel framework for nanomedicine developmentR35GM150758 · NIGMS · UNIVERSITY OF OKLAHOMA · PI Stefan Wilhelm · 2023 to 2026
$1.5M
NIGMS NIH HHS P20 GM135009NIGMS NIH HHS R35 GM150758
6 · The paper itself

Abstract

The predictive bottom-up synthesis of monodisperse and biocompatible gold nanoparticles using seed-mediated growth procedures is limited by a lack of mathematical models relating reaction components to the final nanoparticle diameter. In this study, we used unique quantitative analytical methods at the single-nanoparticle level to identify the mathematical relationship between the moles of precursor ionic gold and the moles of nanoparticle seeds to synthesize monodisperse gold nanoparticles within ~5% of the target diameter in the ~10 to 120 nm size range. We investigated two commonly used gold nanoparticle syntheses, i.e., the formation of (i) citrate-coated, and (ii) cetyltrimethylammonium chloride (CTAC)-coated gold nanoparticles. Additionally, we developed a surface engineering approach using a physical replacement method that replaces cytotoxic CTAC with biocompatible citrate moieties. We confirmed the successful surface removal of CTAC using several analytical methods and demonstrated biocompatibility with cell viability tests. Our study provides tools and methods by which monodisperse and biocompatible gold nanoparticles can be predictably synthesized for potential downstream biomedical applications.

Indexed as

biocompatibilitygold nanoparticlesmonodispersitynanoparticle synthesissingle particle ICP-MS

Identifiers

PMID40740164
PMCPMC12308639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.